Keyphrases
3-design
20%
Adverse Events
60%
Clinical Trial Design
100%
Cohort Size
20%
Common Toxicity Criteria
20%
Continual Reassessment Method
100%
Dose Level
20%
Dose-finding Trial
100%
Dose-limiting Toxicity
40%
Dose-toxicity Relationship
20%
Improved Estimation
20%
Maximum Tolerated Dose
20%
Outcome-based
20%
Phase I Trial
40%
Proportional Odds
20%
Proportional Odds Assumption
20%
Proportional Odds Model
100%
Relationship Model
20%
Safety Criteria
20%
Sensitivity Analysis
20%
Simulation Study
20%
Small Sample Size
20%
Suboptimal Dose
20%
Target Dose
20%
Toxic Dose
20%
Toxicity Endpoints
20%
Toxicity Outcomes
40%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Clinical Trial Design
100%
Dose Toxicity
33%
Maximum Tolerated Dose
33%
Phase I Trials
66%
Mathematics
Method Performs
20%
Proportional Odds Assumption
20%
Reassessment
100%
Simulation Study
20%
Treated Patient
20%
Trial Design
100%